Navigation Links
Sanguine Appoints Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to Clinical Advisory Board and Ethics Committee
Date:11/7/2012

VALENCIA, Calif., Nov. 7, 2012 /PRNewswire/ -- Sanguine BioSciences, Inc., a biotechnology company providing transparency to patients in biomedical research, has named Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to its Clinical Advisory Board and Ethics Committee. Ms. Rosario's extensive experience in clinical development and human ethics in clinical trials qualifies her to be the first to join Sanguine's Clinical Advisory Board and Ethics Committee.

Prior to joining Biothera, Inc., Ms. Rosario held several senior positions with MannKind Corporation, serving as Vice President of the Oncology Research Program and as the World Wide Regulatory Affairs Liaison for Oncology. Throughout her career, she has held leadership positions at Chiron Corporation (acquired by Novartis), Aradigm Corporation, Dura Pharmaceuticals, Inc. (acquired by Elan Pharmaceuticals) and Glaxo Wellcome Inc.  At these posts, Ms. Rosario was largely involved with the submission of multiple INDs, NDAs, MAAs in numerous indications, including oncology, immunotherapy and pulmonary.

"I am excited to work with the young, motivated entrepreneurs at Sanguine with the vision of bridging a gap between patients and researchers by collecting biospecimens, characterizing them and making these data available to researchers in an effort to expedite the discovery and availability of new treatments in cancer, among other diseases. I have enjoyed my involvement so far in providing guidance on relevant regulatory topics to ensure compliance with regulatory standards, patient safety, and general advice and direction on activities to move Sanguine forward in their goals and objectives." – Darlene Rosario, B.S., RAC, Vice President of Regulatory Affairs & Quality, Biothera.

"We are excited to have Ms. Rosario advise us on our Regulatory Affairs and Ethical Compliance efforts. Her experiences to
'/>"/>

SOURCE Sanguine BioSciences, Inc.; INVENT Ventures, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. Elsevier / MEDai Appoints Tom Zajac as New President
3. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
4. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
5. BioStorage Technologies Appoints New Member to Board of Directors
6. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
7. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
8. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
9. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
10. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
11. Veracyte Appoints Mark Spring as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015  NASA astronaut Kjell Lindgren , who ... his first mission to the International Space Station , ... 9 a.m. EDT Tuesday, July 7. Lindgren will ... Russia . The interviews will be preceded ... his mission training. To schedule an interview, media ...
(Date:6/30/2015)... 2015  Today, Americord Registry, one of the fastest growing ... , a partner at Kirkland & Ellis LLP, as the ... - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are thrilled about ... Martin Smithmyer , CEO of Americord. "He brings a ... will assist Americord,s growth and vision." Andrew ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... does not sacrifice selectivity to achieve faster flow rates in comparison to nylon ... with significant open space to allow easy liquid flow while trapping particulates as ...
(Date:6/30/2015)... ... ... The maximum number of shares proposed to be purchased in the tender offer ... stock). On June 29, 2015, the last trading day prior to the commencement of ... was $2.29 per share. , The tender offer will expire on July 28, 2015 ...
Breaking Biology Technology:NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2Americord Registry Announces Andrew Horne as Advisory Board Member 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3
... , , , , , , ... , AUDIO: A team ... Click here for more information. , ... , , , , ...
... , SEATTLE, Nov. 20 Dendreon Corporation ... and Drug Administration (FDA) provided written acknowledgement that the Company,s ... complete response. The FDA has assigned a Prescription Drug ... which time it will respond to Dendreon,s amended BLA. ...
... , SEATTLE, Nov. 20 Cell Therapeutics, Inc. (CTI) (Nasdaq ... Appeals reversed a U.S. District Court order and ruled that CTI ... Lash Group, sending the case back to the District Court for ... former third-party reimbursement consultant for CTI,s product TRISENOX, in 2007 seeking ...
Cached Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/30/2015)... Pa. , June 30, 2015 ... the company as CEO to help further develop Genisphere,s ... wealth of partnering experience, having spent much of the ... including Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. ... focus on Technology and Biotech Corporate Finance. He graduated ...
(Date:6/29/2015)... , June 24, 2015 ... of the "Latin America Biomedical Sensors Market - ... offering. The Latin America Biomedical Sensors market ... CAGR of 2.04% over the period 2014-2020 ... adaptable to the genetic formulation of each individual. These ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... announces the latest edition of an essential ... rapidly changing fields of clinical medicine. Covering novel viruses, ... informs scientists and health care professionals about all ... "Virology is currently one of the ...
... 2009The relationships between food, nutrition science, and health outcomes ... variation among individuals and populations is a new factor ... relationships. Hence, the rapidly emerging intersection of nutritional science ... a special issue of OMICS: A Journal of ...
... up a gas tank when the gasoline price hit close ... consumes fuel, which not only increases our vulnerability to foreign ... that will impact adverse change in climate and global warming. ... developing techniques that will lessen our monetary pain at the ...
Cached Biology News:New edition available for essential virology reference 2Nutrigenomics -- developing personalized diets for disease prevention -- part 2 just published in OMICS 2Engineer devises ways to improve gas mileage 2Engineer devises ways to improve gas mileage 3
... Features, Special optically clear polystyrene formulation ... in immunoassay applications , Plates are ... coefficients of variation , Eight-well strips ... strip loss while in use even if ...
...
... Easy-Titer Human IgM Assay Kit to address ... easy-to-perform assay for Human IgM that eliminates ... incorporates a simple mix-and-read assay that allows ... 15-500 ng/ml in approximately 30 minutes. The ...
... and clarification reagent; Ideal for clarifying ... antibodies, proteins, nucleic acids, & proteoglycans; ... and improves downstream processing; Utilizes a ... adsorbent supplied as a suspension in ...
Biology Products: